SISP @ CHIC FORUM 2025

🔬 Breaking It Down: Key Technologies Driving Precision Medicine

First of all, we would like to thank the Department of Pediatrics for the opportunity to present our work. It was a pleasure to share the latest advancements from our lab in spatial biology and organoid technology. We look forward to exploring future collaborations that may help accelerate innovations in pediatric precision medicine.

🚀 High-Throughput Drug Screening

Imagine being able to test thousands of potential drug compounds in just a short time. That’s the power of high-throughput screening—a technology that works like a rapid assembly line for evaluating drug responses. It dramatically speeds up the discovery of effective treatments, helping us get closer to the right therapy, faster.

🧭 Spatial Mapping of Tissue Architecture

This technology allows us to visualize not just what cells are present in a tissue, but where they are and how they’re interacting. Think of it as a highly detailed GPS for your cells. By preserving the spatial context, we can uncover critical insights into how cells behave in disease states and how their microenvironment influences drug response.

🧬 Patient-Derived Organoids (PDOs)

Perhaps the most transformative technology we’re working with—PDOs are miniature, lab-grown versions of a patient's organ or tumor, developed directly from their cells. This enables us to test drug responses in a personalized, preclinical setting. It’s a major leap forward in tailoring the right treatment for the right patient, while avoiding unnecessary side effects from ineffective therapies.

We are excited by the opportunities to partner with pediatric researchers and clinicians to bring these cutting-edge approaches into translational and clinical practice. Let’s work together to shape the future of personalized child health.